Work

AMN107, a Novel Aminopyrimidine Inhibitor of BCR-ABL, Has Pre-Clinical Activity Against Imatinib Mesylate-Resistant Chronic Myeloid Leukemia (CML).

Year: 2004

Type: article

Source: Blood

DOI: 10.1182/blood.v104.11.1983.1983

Authors: Mirna Golemovic, Francis J. Giles, Miloslav Beran, Jorge Cortes, Taghi Manshouri, Hagop Kantarjian, Srdan Verstovsek

Institution: The University of Texas MD Anderson Cancer Center

Language: English

Topic: Chronic Myeloid Leukemia Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2561264952

FWCI: 0.424

Cites:

Cited by: 3

Related to: 10